Cepheid's Q4 Revenues Spike 23 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Thursday that its fourth quarter 2013 revenues increased 23 percent year over year while its profit swung to a net loss.

For the three months ended Dec. 31, 2013, total revenues came in at $113.3 million, up from $92.4 million in the year-ago period and beating the consensus Wall Street estimate of $102.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.